BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34228537)

  • 1. Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus.
    Sato Y; Suenaga T; Kobayashi M; Miyazaki N; Suzuki T; Ishioka K; Suzutani T
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0049421. PubMed ID: 34228537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir).
    Chono K; Katsumata K; Kontani T; Shiraki K; Suzuki H
    Biochem Pharmacol; 2012 Aug; 84(4):459-67. PubMed ID: 22687623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
    Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
    J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target.
    Biswas S; Kleymann G; Swift M; Tiley LS; Lyall J; Aguirre-Hernández J; Field HJ
    J Antimicrob Chemother; 2008 May; 61(5):1044-7. PubMed ID: 18299638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UL52 primase interactions in the herpes simplex virus 1 helicase-primase are affected by antiviral compounds and mutations causing drug resistance.
    Muylaert I; Zhao Z; Elias P
    J Biol Chem; 2014 Nov; 289(47):32583-92. PubMed ID: 25278021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicase-primase complex of herpes simplex virus type 1: a mutation in the UL52 subunit abolishes primase activity.
    Klinedinst DK; Challberg MD
    J Virol; 1994 Jun; 68(6):3693-701. PubMed ID: 8189507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.
    Collot M; Rouard C; Brunet C; Agut H; Boutolleau D; Burrel S
    Antiviral Res; 2016 Apr; 128():1-6. PubMed ID: 26826441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in the human herpes simplex virus type 1 UL52 zinc finger motif results in defective primase activity but can recruit viral polymerase and support viral replication efficiently.
    Chen Y; Livingston CM; Carrington-Lawrence SD; Bai P; Weller SK
    J Virol; 2007 Aug; 81(16):8742-51. PubMed ID: 17553899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity.
    Biswas S; Tiley LS; Zimmermann H; Birkmann A; Field HJ
    Antiviral Res; 2008 Oct; 80(1):81-5. PubMed ID: 18539344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of gly815 in helicase motif V alters the single-stranded DNA-dependent ATPase activity of the herpes simplex virus type 1 helicase-primase.
    Graves-Woodward KL; Weller SK
    J Biol Chem; 1996 Jun; 271(23):13629-35. PubMed ID: 8662872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intertypic herpes simplex virus helicase-primase complex associated with a defect in neurovirulence has reduced primase activity.
    Barrera I; Bloom D; Challberg M
    J Virol; 1998 Feb; 72(2):1203-9. PubMed ID: 9445019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The three-component helicase/primase complex of herpes simplex virus-1.
    Bermek O; Williams RS
    Open Biol; 2021 Jun; 11(6):210011. PubMed ID: 34102080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the putative zinc-binding motif of UL52 demonstrate a complex interdependence between the UL5 and UL52 subunits of the human herpes simplex virus type 1 helicase/primase complex.
    Chen Y; Carrington-Lawrence SD; Bai P; Weller SK
    J Virol; 2005 Jul; 79(14):9088-96. PubMed ID: 15994803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The six conserved helicase motifs of the UL5 gene product, a component of the herpes simplex virus type 1 helicase-primase, are essential for its function.
    Zhu LA; Weller SK
    J Virol; 1992 Jan; 66(1):469-79. PubMed ID: 1309257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in the C-terminal putative Zn2+ finger motif of UL52 severely affects the biochemical activities of the HSV-1 helicase-primase subcomplex.
    Biswas N; Weller SK
    J Biol Chem; 1999 Mar; 274(12):8068-76. PubMed ID: 10075707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.
    Barnard EC; Brown G; Stow ND
    Virology; 1997 Oct; 237(1):97-106. PubMed ID: 9344911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure.
    Biswas S; Miguel RN; Sukla S; Field HJ
    J Gen Virol; 2009 Aug; 90(Pt 8):1937-1942. PubMed ID: 19403757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The UL8 subunit of the herpes simplex virus helicase-primase complex is required for efficient primer utilization.
    Sherman G; Gottlieb J; Challberg MD
    J Virol; 1992 Aug; 66(8):4884-92. PubMed ID: 1321275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.
    Tenney DJ; Hurlburt WW; Micheletti PA; Bifano M; Hamatake RK
    J Biol Chem; 1994 Feb; 269(7):5030-5. PubMed ID: 8106478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment of polymerase to herpes simplex virus type 1 replication foci in cells expressing mutant primase (UL52) proteins.
    Carrington-Lawrence SD; Weller SK
    J Virol; 2003 Apr; 77(7):4237-47. PubMed ID: 12634381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.